Evaluation of Factors Contributing to Potential Drug-Drug Interactions in Cardiovascular Disease Management: A Retrospective Study
Journal Title: Healthcraft Frontiers - Year 2024, Vol 2, Issue 2
Abstract
A retrospective analysis was conducted to assess potential drug-drug interactions (pDDIs) in the management of cardiovascular diseases, evaluating 500 prescriptions from hospitalized patients between January 1 and April 1, 2023. Using Medscape online software for the identification of drug-drug interactions (DDIs) and SPSS version 21 for statistical analysis, the study documented a 93% occurrence rate of pDDIs across the prescriptions. These interactions were categorized as serious (15% of cases, n=760, maximum per encounter: 4, mean: 1.52 ±1.064), significant (75.6% of cases, n=3855, maximum per encounter: 30, mean: 7.71 ±4.583), and minor (9.5% of cases, n=485, maximum per encounter: 4, mean: 0.95 ±1.025). On average, 9.5 medications were prescribed per patient. Factors significantly associated with the incidence of pDDIs included age (r= 0.921, P < 0.01), presence of concurrent diseases (r= 0.782, P < 0.01), length of hospital stay (r= 0.559, P < 0.01), and the number of prescribed drugs (r= 0.472, P < 0.01). The most frequent interacting combinations were identified, with Clopidogrel + Enoxaparin (38.15%, n=290) and Enoxaparin + Aspirin (26.92%, n=210) being the most common, followed by other notable combinations. The study recorded adverse drug reactions in 15 patients. This investigation highlights a significant prevalence of pDDIs, particularly in cases of polypharmacy among cardiovascular patients. It underscores the critical need for systematic analysis and vigilant monitoring of prescriptions prior to drug administration by healthcare professionals.
Authors and Affiliations
Awais Khan, Haya Hussain
Keywords
Related Articles
- EP ID EP744650
- DOI https://doi.org/10.56578/hf020202.
- Views 48
- Downloads 0
A Blockchain-Based Blood Donation System: Enhancing Transparency, Accountability, and Sustainability in Healthcare
The increasing global population has led to a corresponding rise in the demand for blood in healthcare settings, necessitating the development of efficient and transparent blood management systems. The process of blood d...
Evaluation of Factors Contributing to Potential Drug-Drug Interactions in Cardiovascular Disease Management: A Retrospective Study
A retrospective analysis was conducted to assess potential drug-drug interactions (pDDIs) in the management of cardiovascular diseases, evaluating 500 prescriptions from hospitalized patients between January 1 and Apri...
Investigating Malaria Susceptibility in Central Maluku District: A Focus on Anopheles Mosquito Habitats
Malaria remains a formidable challenge to global public health, with an estimated 241 million cases reported across 85 endemic countries in 2020. Within this context, Indonesia, and particularly the Central Maluku Rege...
Segmentation and Classification of Skin Cancer in Dermoscopy Images Using SAM-Based Deep Belief Networks
In the field of computer-aided diagnostics, the segmentation and classification of biomedical images play a pivotal role. This study introduces a novel approach employing a Self-Augmented Multistage Deep Learning Network...
A Comparative Analysis of Side Effects from the Third Dose of COVID-19 Vaccines in Palestine and Jordan
In this cross-sectional study, the prevalence and characteristics of adverse effects following the administration of the third dose of the coronavirus disease 2019 (COVID-19) vaccines were compared between recipients i...